Abstract
In neurons, the process of axonal transport helps maintain health and homeostasis for normal neuronal functions. Protein products, synthesized in the cell body and organelles such as mitochondria, are transported via molecular “motors” to the synapse for incorporation into membranes or cytoskeletal architecture, release into the synaptic cleft, or use in synaptic functioning. Retrograde transport occurs when substances, such as trophic factors, are taken up from the synaptic cleft via endocytosis and are transported back to the cell body to modulate further protein synthesis. Although retrograde transport is an important neuronal process, this chapter will focus on imaging of anterograde axonal transport and the effects of aging and neurodegeneration. Because axonal transport mechanisms become even more critical to maintain neuronal function in neuronal populations with long axonal projections, perturbations of axonal transport may contribute to the selective vulnerability of cortical projection neurons in neurodegenerative processes such as Alzheimer’s disease (AD). With the increasing longevity of the world’s population, aging and age-related diseases are becoming a major healthcare issue. Research in the areas of brain aging is critical, not only to maintaining life, but also to maintaining quality of life and sustaining a fully functional, independent, elderly population. Aging is also known to be a major risk factor for AD. According to pathological observations, cortical projection neurons are particularly vulnerable to AD pathophysiology (Hof et al., 1990). In such neurons, the process of axonal transport is particularly crucial to sustaining neuronal homeostasis and functions. Certain systems can be challenging to investigate non-invasively due to the relative inaccessibility of some brain regions and the technical challenges inherent in studying dynamic, sub-cellular processes. Therefore, the methodology to study axonal transport in living brains has been limited. This chapter will present on-going efforts to investigate this critical process using recently developed in vivo imaging techniques.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AD:
-
Alzheimer’s disease
- APP:
-
Amyloid precursor protein
- ATP:
-
Adenosine triphosphate
- Aβ:
-
Amyloid-beta
- FDG-PET:
-
(F-18) Flurodeoxyglucose and positron emission tomography
- GSK-3:
-
Glycogen synthase kinase 3
- MEMRI:
-
Manganese-enhanced magnetic resonance imaging
- VOI:
-
Volume of interest
References
Adalbert R, Nogradi A, Babetto E, Janeckova L, Walker SA, Kerschensteiner M, Misgeld T, Coleman MP (2009) Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies. Brain 132(Pt 2):402–416
Albers MW, Tabert MH, Devanand DP (2006) Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep 6(5):379–386
Aschner M, Vrana KE, Zheng W (1999) Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 20(2–3):173–180
Attems J, Jellinger KA (2006) Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin Neuropathol 25(6):265–271
Barrios FA, Gonzalez L, Favila R, Alonso ME, Salgado PM, Diaz R, Fernandez-Ruiz J (2007) Olfaction and neurodegeneration in HD. Neuroreport 18(1):73–76
Brady ST (2000) Neurofilaments run sprints not marathons. Nat Cell Biol 2(3):E43–E45
Brenneman KA, Wong BA, Buccellato MA, Costa ER, Gross EA, Dorman DC (2000) Direct olfactory transport of inhaled manganese ((54)MnCl(2)) to the rat. Toxicol Appl Pharmacol 169(3):238–248
Brunetti M, Miscena A, Salviati A, Gaiti A (1987) Effect of aging on the rate of axonal transport of choline-phosphoglycerides. Neurochem Res 12(1):61–65
Caccamo A, Oddo S, Tran LX, LaFerla FM (2007) Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol 170(5):1669–1675
Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avila J, Jones PK, Castellani RJ, Smith MA, Perry G (2003) Microtubule reduction in Alzheimer’s disease and aging is independent of tau filament formation. Am J Pathol 162(5):1623–1627
Cross DJ, Flexman JA, Anzai Y, Maravilla KR, Minoshima S (2008) Age-related decrease in axonal transport measured by MR imaging in vivo. Neuroimage 39(3):915–926
Cross DJ, Flexman JA, Anzai Y, Sasaki T, Treuting PM, Maravilla KR, Minoshima S (2007) In vivo manganese MR imaging of calcium influx in spontaneous rat pituitary adenoma. AJNR Am J Neuroradiol 28(10):1865–1871
Dai J, Buijs RM, Kamphorst W, Swaab DF (2002) Impaired axonal transport of cortical neurons in Alzheimer’s disease is associated with neuropathological changes. Brain Res 948(1–2):138–144
Engel T, Goni-Oliver P, Lucas JJ, Avila J, Hernandez F (2006) Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. J Neurochem 99(6):1445–1455. Epub 2006 Oct 24
Enwere E, Shingo T, Gregg C, Fujikawa H, Ohta S, Weiss S (2004) Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination. J Neurosci 24(38):8354–8365
Fiala J, Feinberg M, Peters A, Barbas H (2007) Mitochondrial degeneration in dystrophic neurites of senile plaques may lead to extracellular deposition of fine filaments. Brain Struct Funct 212(2):195–207
Fibiger HC, Pudritz RE, McGeer PL, McGeer EG (1972) Axonal transport in nigro-striatal and nigro-thalamic neurons: effects of medial forebrain bundle lesions and 6-hydroxydopamine. J Neurochem 19(7):1697–1708
Firbank MJ, Blamire AM, Krishnan MS, Teodorczuk A, English P, Gholkar A, Harrison RM, O’Brien JT (2007) Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer’s disease. Psychiatry Res 155:135–145
Frolkis VV, Tanin SA, Gorban YN (1997) Age-related changes in axonal transport. Exp Gerontol 32(4–5):441–450
Gallez B, Baudelet C, Geurts M (1998) Regional distribution of manganese found in the brain after injection of a single dose of manganese-based contrast agents. Magn Reson Imaging 16(10):1211–1215
Gavin CE, Gunter KK, Gunter TE (1990) Manganese and calcium efflux kinetics in brain mitochondria. relevance to manganese toxicity. Biochem J 266(2):329–334
Gianutsos G, Morrow GR, Morris JB (1997) Accumulation of manganese in rat brain following intranasal administration. Fundam Appl Toxicol 37(2):102–105
Ho DT, Schlosser P, Caplow T (2002) Determination of longitudinal dispersion coefficient and net advection in the tidal hudson river with a large-scale, high resolution SF6 tracer release experiment. Environ Sci Technol 36(15):3234–3241
Hof PR, Cox K, Morrison JH (1990) Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer’s disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol 301(1):44–54
Jacob JM, O’Donoghue DL (1995) Direct measurement of fast axonal transport rates in corticospinal axons of the adult rat. Neurosci Lett 197(1):17–20
Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414(6864):643–648
Kasa P, Papp H, Kovacs I, Forgon M, Penke B, Yamaguchi H (2000) Human amyloid-beta1-42 applied in vivo inhibits the fast axonal transport of proteins in the sciatic nerve of rat. Neurosci Lett 278(1–2):117–119
Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B (2004) Imaging brain amyloid in Alzheimer’s disease with pittsburgh compound-B. Ann Neurol 55(3):306–319
Kreutzberg GW (1969) Neuronal dynamics and axonal flow. IV. Blockage of intra-axonal enzyme transport by colchicine. Proc Natl Acad Sci USA 62(3):722–728
Leergaard TB, Bjaalie JG, Devor A, Wald LL, Dale AM (2003) In vivo tracing of major rat brain pathways using manganese-enhanced magnetic resonance imaging and three-dimensional digital atlasing. Neuroimage 20(3):1591–1600
Levin BE (1977) Axonal transport of [3H]fucosyl glycoproteins in noradrenergic neurons in the rat brain. Brain Res 130(3):421–432
Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534):1487–1491
Luzzi S, Snowden JS, Neary D, Coccia M, Provinciali L, Lambon Ralph MA (2007) Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 45(8):1823–1831
Masuoka DT, Jonsson G, Finch CE (1979) Aging and unusual catecholamine-containing structures in the mouse brain. Brain Res 169(2):335–341
McNeill TH, Koek LL, Haycock JW (1984) The nigrostriatal system and aging. Peptides 5(Suppl 1):263–268
McQuarrie IG, Brady ST, Lasek RJ (1989) Retardation in the slow axonal transport of cytoskeletal elements during maturation and aging. Neurobiol Aging 10(4):359–365
Minoshima S, Cross D (2008) In vivo imaging of axonal transport using MRI: aging and Alzheimer’s disease. Eur J Nucl Med Mol Imaging, 35(Suppl 1):S89–92
Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol 42(1):85–94
Morfini G, Pigino G, Beffert U, Busciglio J, Brady ST (2002) Fast axonal transport misregulation and Alzheimer’s disease. Neuromolecular Med 2(2):89–99
Mudher A, Shepherd D, Newman TA, Mildren P, Jukes JP, Squire A, Mears A, Drummond JA, Berg S, MacKay D, Asuni AA, Bhat R, Lovestone S (2004) GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol Psychiatry 9(5):522–530
Narita K, Kawasaki F, Kita H (1990) Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Res 510(2):289–295
NIH (2007) news briefs: new Alzheimer’s clinical trials to be undertaken by NIA nationawide consortium. Am J Alzheimers Dis Other Demen 21:460–462. doi:10.1177/1533317506297573
Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 102(19):6990–6995. Epub 2005 May 2
Ochs S (1972) Fast transport of materials in mammalian nerve fibers. Science 176(32):252–260
Ochs S (1973) Effect of maturation and aging on the rate of fast axoplasmic transport in mammalian nerve. Prog Brain Res 40(0):349–362
Ochs S (1975) A unitary concept of axoplasmic transport based on the transport filament hypothesis. In: Bradley W et al. (eds) Recent advances in myology, vol 360. Excerpta Medica, Amsterdam, pp 189–194
Parhad IM, Scott JN, Cellars LA, Bains JS, Krekoski CA, Clark AW (1995) Axonal atrophy in aging is associated with a decline in neurofilament gene expression. J Neurosci Res 41(3):355–366
Pautler RG, Koretsky AP (2002) Tracing odor-induced activation in the olfactory bulbs of mice using manganese-enhanced magnetic resonance imaging. Neuroimage 16(2):441–448
Pautler RG, Silva AC, Koretsky AP (1998) In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 40(5):740–748
Phiel CJ, Wilson CA, Lee VM, Klein PS (2003) GSK-3alpha regulates production of Alzheimer’s disease amyloid-beta peptides. Nature 423(6938):435–439
Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J (2003) Alzheimer’s presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci 23(11):4499–4508
Praprotnik D, Smith MA, Richey PL, Vinters HV, Perry G (1996) Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer’s disease. Acta Neuropathol (Berl) 91(3):226–235
Rashid DJ, Bononi J, Tripet BP, Hodges RS, Pierce DW (2005) Monomeric and dimeric states exhibited by the kinesin-related motor protein KIF1A. J Pept Res 65(6):538–549
Rockenstein E, Torrance M, Adame A, Mante M, Bar-on P, Rose JB, Crews L, Masliah E (2007) Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer’s disease are associated with reduced amyloid precursor protein phosphorylation. J Neurosci 27(8):1981–1991
Saleem KS, Pauls JM, Augath M, Trinath T, Prause BA, Hashikawa T, Logothetis NK (2002) Magnetic resonance imaging of neuronal connections in the macaque monkey. Neuron 34(5):685–700
Shea TB (2000) Microtubule motors, phosphorylation and axonal transport of neurofilaments. J Neurocytol 29(11/12):873–887
Sloot WN, Gramsbergen JB (1994) Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 657(1/2):124–132
Smith KD, Kallhoff V, Zheng H, Pautler RG (2007) In vivo axonal transport rates decrease in a mouse model of Alzheimer’s disease. Neuroimage 35(4):1401–1408. Epub 2007 Feb 12
Stokin GB, Goldstein LS (2006a) Axonal transport and Alzheimer’s disease. Annu Rev Biochem 75:607–627
Stokin GB, Goldstein LS (2006b) Linking molecular motors to Alzheimer’s disease. J Physiol Paris 99(2/3):193–200
Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer’s disease. Science 307(5713):1282–1288
Stromska DP, Ochs S (1982) Axoplasmic transport in aged rats. Exp Neurol 77(1):215–224
Takashima A (2006) GSK-3 is essential in the pathogenesis of Alzheimer’s disease. J Alzheimers Dis 9(3 Suppl):309–317
Takeda A, Kodama Y, Ishiwatari S, Okada S (1998) Manganese transport in the neural circuit of rat CNS. Brain Res Bull 45(2):149–152
Tesseur I, Van DJ, Bruynseels K, Bronfman F, Sciot R, Van LA, Van LF (2000) Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am J Pathol 157(5):1495–1510
Tjalve H, Henriksson J (1999) Uptake of metals in the brain via olfactory pathways. Neurotoxicology 20(2–3):181–195
Tjalve H, Henriksson J, Tallkvist J, Larsson BS, Lindquist NG (1996) Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol Toxicol 79(6):347–356
Tomishige M, Klopfenstein DR, Vale RD (2002) Conversion of Unc104/KIF1A kinesin into a processive motor after dimerization. Science 297(5590):2263–2267
Uchida A, Tashiro T, Komiya Y, Yorifuji H, Kishimoto T, Hisanaga S (2004) Morphological and biochemical changes of neurofilaments in aged rat sciatic nerve axons. J Neurochem 88(3):735–745
Vahlsing HL, Hirschl RB, Feringa ER (1981) Axoplasmic flow of tritiated proline in the corticospinal tract of the rat. Cell Tissue Res 214(2):279–287
Van der Linden A, Verhoye M, Van Meir V, Tindemans I, Eens M, Absil P, Balthazart J (2002) In vivo manganese-enhanced magnetic resonance imaging reveals connections and functional properties of the songbird vocal control system. Neuroscience 112(2):467–474
Verdu E, Ceballos D, Vilches JJ, Navarro X (2000) Influence of aging on peripheral nerve function and regeneration. J Peripher Nerv Syst 5(4):191–208
Watanabe T, Michaelis T, Frahm J (2001) Mapping of retinal projections in the living rat using high-resolution 3D gradient-echo MRI with Mn2+-induced contrast. Magn Reson Med 46(3):424–429
Weiss P, Hiscoe HB (1948) Experiments on the mechanism of nerve growth. J Exp Zool 107(3):315–395
Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, Martinez D, Joyce S, Trojanowski JQ, Lee VM (2004) Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. J Neurosci 24(19):4657–4667
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cross, D.J., Minoshima, S. (2011). In Vivo Imaging of Axonal Transport in Aging and Alzheimer’s Disease. In: Nixon, R., Yuan, A. (eds) Cytoskeleton of the Nervous System. Advances in Neurobiology, vol 3. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6787-9_23
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6787-9_23
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6786-2
Online ISBN: 978-1-4419-6787-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)